Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

taVNS Therapy for Social Anxiety Disorder

Official title: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)for Social Anxiety Disorder: A Randomized Controlled Clinical Trial.

Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT07772401 · Data updated 2026-11-12

This study tests whether non-invasive taVNS can help reduce social anxiety symptoms in adults with SAD.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment50 (estimated)
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Academic / other
Locations2 sites (Hangzhou, Zhejiang and 1 other locations)
StatusRecruiting
StartedSeptember 5, 2025
Main results expectedAugust 31, 2026
Study endsDecember 1, 2026
Registry record updatedOctober 19, 2026
Trial IDNCT07772401 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 with a DSM-5 diagnosis of Social Anxiety Disorder and LSAS ≥30 and CLASPI >30, who consent to participate.

Probably not a fit

Individuals without a reduction in symptoms or with adverse events limiting participation may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blind, sham-controlled pilot study evaluating transcutaneous auricular vagus nerve stimulation (taVNS) for social anxiety disorder. Participants receive either active taVNS or sham stimulation using identical devices, with stimulation intensity tailored to tolerance (up to 5 mA) or a sham 0.1 mA. The trial aims to assess preliminary efficacy on social anxiety symptoms and to monitor safety and treatment adherence. Outcomes will inform future larger trials in this area.

Why it matters

Potential benefit: If successful, taVNS could offer a non-invasive treatment option to reduce social anxiety symptoms.

How similar studies have gone: Prior small studies suggest potential anxiolytic effects of taVNS, but rigorous evidence in SAD is still emerging.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Fulfillment of the DSM-5 diagnostic criteria for Social Anxiety Disorder (SAD). A Liebowitz Social Anxiety Scale (LSAS) score of ≥30 and a Clinical Global Social Phobia Inventory score greater than 30 Age between 18 and 70 years. Voluntary provision of written informed consent.

Exclusion Criteria:

A lifetime history of bipolar disorder, schizophrenia, or obsessive-compulsive disorder.

Any cognitive impairments that could interfere with the study. Significant suicidal ideation or behavior within the past six months. Patients with rapidly deteriorating conditions. Previous taVNS treatment within the past month. Contraindications to auricular vagus nerve stimulation, such as ear infections, inflammation, skin lesions, or hypersensitivity of the ear.

Presence of a pacemaker or other implanted medical devices, or severe neurological, renal, cardiovascular, or hepatic diseases.

Concurrent engagement in any form of psychotherapy. History of psychotropic medications or alcohol abuse. Inability to comply with psychological assessments. Incapable of providing informed consent. Pregnant or lactating. Other reasons as deemed unsuitable for inclusion by the research team.

Where it's running

  • The Second Affiliated Hospital Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting
  • The Second Affiliated Hospital Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Not yet recruiting

Study contacts

  • Principal investigator: Han Xu — The Second Affiliated Hospital Zhejiang University of medicine
  • Study coordinator: Bin Gao
  • Email: zjugaobin@163.com
  • Phone: +8618768188021

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.